Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Adenosine and Purinergic Signaling, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses.
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
CD163<sup>+</sup> tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes
Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage